# Phase 1 Study of KHK2898 in Subjects With Advanced Solid Tumors

> **NCT01516645** · PHASE1 · TERMINATED · sponsor: **Kyowa Kirin Co., Ltd.** · enrollment: 14 (actual)

## Conditions studied

- Solid Tumour

## Interventions

- **DRUG:** KHK2898

## Key facts

- **NCT ID:** NCT01516645
- **Lead sponsor:** Kyowa Kirin Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-01
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2017-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01516645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01516645, "Phase 1 Study of KHK2898 in Subjects With Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01516645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*